Both semaglutide and tirzepatide are highly effective in improving blood sugar control: Semaglutide has been shown to lower A1C (a measure of long-term blood sugar levels) by 1.5% to 2%, with consistent results in clinical trials
The gap between the 9 mg and 12 mg arms is narrow (about 2.3 percentage points) relative to the gap between either active arm and placebo, a pattern that has implications for dose selection in a real-world setting
This is a GIP, GLP-1, and glucagon triple hormone receptor agonist
GLP-1 RA and Synaptic Plasticity Synaptic plasticity refers to the adjustable strength of connections between nerve cells, known as synapses
Following pre-treatment, the medium was removed, and cells were exposed to hydrogen peroxide (300 M
Similarly, in another study by Lui et al